United States Pharmaceuticals

Avidity Biosciences Inc (RNAM)

Track

Track

Ticker: RNAM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Avidity Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
McCarthy Teresa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
155.99
Quantity 11,755 -12.8%
Value US$4,079,749
McCarthy Teresa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
218.47
Quantity 7,909 -46.6%
Value US$4,800,405
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
82.20
Quantity 56,108 +28.7%
Value US$4,685,827
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
72.45
Quantity 2,017 -5.5%
Value US$146,132
MacLean Michael F Chief Financial Officer Officer
Transaction date
Planned sale
Price
72.45
Quantity 2,735 -4.4%
Value US$198,151
MacLean Michael F Chief Financial Officer Officer
Transaction date
Planned sale
Price
72.45
Quantity 1,807 -2.8%
Value US$130,917
Flanagan W. Michael Chief Scientific Officer Officer
Transaction date
Planned sale
Price
72.45
Quantity 2,558 -2.9%
Value US$185,327
Flanagan W. Michael Chief Scientific Officer Officer
Transaction date
Planned sale
Price
72.45
Quantity 3,976 -4.3%
Value US$288,061
3.5
Boyce Sarah President and CEO Executive Director
Transaction date
Planned sale
Price
72.45
Quantity 7,993 -2.9%
Value US$579,093
3.5
Boyce Sarah President and CEO Executive Director
Transaction date
Planned sale
Price
72.45
Quantity 6,394 -2.3%
Value US$463,245
1.2
LEVIN ARTHUR A Non-Executive Director
Transaction date
Planned sale
Price
72.45
Quantity 1,758 -9.6%
Value US$127,367
Calderaro Charles III Chief Technical Officer Officer
Transaction date
Planned sale
Price
72.23
Quantity 3,727 -7.0%
Value US$269,201
3.5
Boyce Sarah President and CEO Executive Director
Transaction date
Planned sale
Price
72.23
Quantity 8,576 -2.9%
Value US$619,444
Flanagan W. Michael Chief Scientific Officer Officer
Transaction date
Planned sale
Price
72.23
Quantity 2,373 -2.5%
Value US$171,402
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
72.23
Quantity 2,373 -6.1%
Value US$171,402
Moriarty John B Chief Legal Officer Officer
Transaction date
Planned sale
Price
72.23
Quantity 2,374 -3.1%
Value US$171,474
MacLean Michael F Chief Financial Officer Officer
Transaction date
Planned sale
Price
72.23
Quantity 1,974 -3.0%
Value US$142,582
McCarthy Teresa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
72.23
Quantity 1,965 -1.7%
Value US$141,932
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
47.54
Quantity 2,209 -5.4%
Value US$105,015
McCarthy Teresa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
50.15
Quantity 20,000 -17.1%
Value US$1,003,058
Mosbrooker Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
45.38
Quantity 6,562 -10.7%
Value US$297,771
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
40.58
Quantity 2,208 -5.4%
Value US$89,601
McCarthy Teresa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
41.41
Quantity 15,000 -13.4%
Value US$621,142
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
45.41
Quantity 1,542 -3.8%
Value US$70,022
Flanagan W. Michael Chief Scientific Officer Officer
Transaction date
Planned sale
Price
38.94
Quantity 20,000 -20.0%
Value US$778,702
WILLIAM MICHAEL FLANAGAN Officer Officer
Transaction date
Proposed sale
Price
46.40
Quantity 20,000
Value US$928,000
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 15,000 -21.6%
Value US$750,000
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 14,500 -17.3%
Value US$725,000
2.8
WILSON TROY EDWARD Chairman
Transaction date
Proposed sale
Price
50.00
Quantity 95,052
Value US$4,752,600
3.5
SARAH BOYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
48.47
Quantity 50,000
Value US$2,423,500
3.5
Boyce Sarah President and CEO Executive Director
Transaction date
Planned sale
Price
49.95
Quantity 50,000 -14.1%
Value US$2,497,435
Mosbrooker Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
47.07
Quantity 6,563 -10.7%
Value US$308,936
ERIC MOSBROOKER Officer Officer
Transaction date
Proposed sale
Price
47.23
Quantity 19,688
Value US$929,864
Gallagher Kathleen P. Chief Program Officer Officer
Transaction date
Planned sale
Price
47.42
Quantity 188 -0.4%
Value US$8,915
3.5
Boyce Sarah President and CEO Executive Director
Transaction date
Planned sale
Price
49.39
Quantity 25,000 -7.6%
Value US$1,234,700
3.5
SARAH BOYCE Director; Officer Executive Director
Transaction date
Proposed sale
Price
47.82
Quantity 25,000
Value US$1,195,500
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.40
Quantity 2,208 -5.4%
Value US$102,462
TERESA MCCARTHY Officer Officer
Transaction date
Proposed sale
Price
46.07
Quantity 45,000
Value US$2,073,150
McCarthy Teresa Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
46.56
Quantity 10,000 -9.3%
Value US$465,632
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.66
Quantity 1,542 -3.8%
Value US$71,950
STEVEN GEORGE HUGHES Officer Officer
Transaction date
Proposed sale
Price
46.23
Quantity 9,709
Value US$448,847
MacLean Michael F Chief Financial Officer Officer
Transaction date
Planned sale
Price
42.73
Quantity 30,914 -32.0%
Value US$1,320,844
Mosbrooker Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
44.06
Quantity 6,120 -10.0%
Value US$269,663
Mosbrooker Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
44.06
Quantity 124,687 -67.1%
Value US$5,494,033
1.2
LEVIN ARTHUR A Non-Executive Director
Transaction date
Planned sale
Price
47.62
Quantity 107,500 -84.5%
Value US$5,118,881
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 17,777 -50.0%
Value US$799,965
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 17,777 -50.0%
Value US$799,965
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 15,000 -5.0%
Value US$675,000
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 15,000 -5.0%
Value US$675,000
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 7,500 -9.7%
Value US$337,500
2.8
WILSON TROY EDWARD Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 22,000 -24.1%
Value US$990,000
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
42.74
Quantity 33,983 -46.6%
Value US$1,452,342
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
42.74
Quantity 17,667 -19.5%
Value US$755,040
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
42.74
Quantity 6,167 -7.8%
Value US$263,561
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
42.74
Quantity 12,334 -14.5%
Value US$527,122
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
42.74
Quantity 11,283 -13.4%
Value US$482,205
2.8
WILSON TROY EDWARD Chairman
Transaction date
Proposed sale
Price
45.00
Quantity 95,054
Value US$4,277,430
ERIC MOSBROOKER Officer Officer
Transaction date
Proposed sale
Price
38.26
Quantity 130,807
Value US$5,004,676
STEVEN GEORGE HUGHES Officer Officer
Transaction date
Proposed sale
Price
38.26
Quantity 81,434
Value US$3,115,665
1.2
ARTHUR LEVIN Director Non-Executive Director
Transaction date
Proposed sale
Price
38.26
Quantity 107,500
Value US$4,112,950
MICHAEL MACLEAN Officer Officer
Transaction date
Proposed sale
Price
38.26
Quantity 30,914
Value US$1,182,770
Moriarty John B Chief Legal Officer Officer
Transaction date
Planned sale
Price
36.21
Quantity 2,245 -4.5%
Value US$81,291
Gallagher Kathleen P. Chief Program Officer Officer
Transaction date
Planned sale
Price
30.24
Quantity 911 -1.8%
Value US$27,549
KATHLEEN GALLAGHER Officer Officer
Transaction date
Proposed sale
Price
29.80
Quantity 911
Value US$27,148
Flanagan W. Michael Chief Scientific Officer Officer
Transaction date
Planned sale
Price
32.88
Quantity 20,000 -20.0%
Value US$657,694
WILLIAM MICHAEL FLANAGAN Officer Officer
Transaction date
Proposed sale
Price
33.62
Quantity 20,000
Value US$672,400
Gallagher Kathleen P. Chief Program Officer Officer
Transaction date
Planned sale
Price
32.48
Quantity 5,875 -10.4%
Value US$190,833
KATHLEEN GALLAGHER Officer Officer
Transaction date
Proposed sale
Price
30.98
Quantity 5,875
Value US$182,008
Gallagher Kathleen P. Chief Program Officer Officer
Transaction date
Planned sale
Price
32.40
Quantity 5,875 -10.4%
Value US$190,324
KATHLEEN GALLAGHER Officer Officer
Transaction date
Proposed sale
Price
32.65
Quantity 5,875
Value US$191,819
Gallagher Kathleen P. Chief Program Officer Officer
Transaction date
Planned sale
Price
27.83
Quantity 329 -0.6%
Value US$9,155
Gallagher Kathleen P. Chief Program Officer Officer
Transaction date
Planned sale
Price
27.83
Quantity 5,546 -9.9%
Value US$154,331
3.5
Boyce Sarah President and CEO Executive Director
Transaction date
Planned sale
Price
31.06
Quantity 31,540 -9.3%
Value US$979,563
Flanagan W. Michael Chief Scientific Officer Officer
Transaction date
Planned sale
Price
31.06
Quantity 11,780 -12.8%
Value US$365,868
Hughes Steven George Chief Medical Officer Officer
Transaction date
Planned sale
Price
31.06
Quantity 9,578 -11.6%
Value US$297,491
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-23 2026-01-21 PlS Planned sale
McCarthy Teresa

Chief Human Resources Officer

Officer
11,755 -12.8%
155.99
US$4,079,749 		11,755 -12.8% 155.99 US$4,079,749
2026-01-23 2026-01-21 PlS Planned sale
McCarthy Teresa

Chief Human Resources Officer

Officer
7,909 -46.6%
218.47
US$4,800,405 		7,909 -46.6% 218.47 US$4,800,405
2026-01-23 2026-01-21 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
56,108 +28.7%
82.20
US$4,685,827 		56,108 +28.7% 82.20 US$4,685,827
2026-01-23 2026-01-21 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
2,017 -5.5%
72.45
US$146,132 		2,017 -5.5% 72.45 US$146,132
2026-01-23 2026-01-21 PlS Planned sale
MacLean Michael F

Chief Financial Officer

Officer
2,735 -4.4%
72.45
US$198,151 		2,735 -4.4% 72.45 US$198,151
2026-01-23 2026-01-21 PlS Planned sale
MacLean Michael F

Chief Financial Officer

Officer
1,807 -2.8%
72.45
US$130,917 		1,807 -2.8% 72.45 US$130,917
2026-01-23 2026-01-21 PlS Planned sale
Flanagan W. Michael

Chief Scientific Officer

Officer
2,558 -2.9%
72.45
US$185,327 		2,558 -2.9% 72.45 US$185,327
2026-01-23 2026-01-21 PlS Planned sale
Flanagan W. Michael

Chief Scientific Officer

Officer
3,976 -4.3%
72.45
US$288,061 		3,976 -4.3% 72.45 US$288,061
2026-01-23 2026-01-21 PlS Planned sale
3.5
Boyce Sarah

President and CEO

Executive Director
7,993 -2.9%
72.45
US$579,093 		7,993 -2.9% 72.45 US$579,093
2026-01-23 2026-01-21 PlS Planned sale
3.5
Boyce Sarah

President and CEO

Executive Director
6,394 -2.3%
72.45
US$463,245 		6,394 -2.3% 72.45 US$463,245
2026-01-23 2026-01-21 PlS Planned sale
1.2
LEVIN ARTHUR A
Non-Executive Director
1,758 -9.6%
72.45
US$127,367 		1,758 -9.6% 72.45 US$127,367
2026-01-09 2026-01-07 PlS Planned sale
Calderaro Charles III

Chief Technical Officer

Officer
3,727 -7.0%
72.23
US$269,201 		3,727 -7.0% 72.23 US$269,201
2026-01-09 2026-01-07 PlS Planned sale
3.5
Boyce Sarah

President and CEO

Executive Director
8,576 -2.9%
72.23
US$619,444 		8,576 -2.9% 72.23 US$619,444
2026-01-09 2026-01-07 PlS Planned sale
Flanagan W. Michael

Chief Scientific Officer

Officer
2,373 -2.5%
72.23
US$171,402 		2,373 -2.5% 72.23 US$171,402
2026-01-09 2026-01-07 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
2,373 -6.1%
72.23
US$171,402 		2,373 -6.1% 72.23 US$171,402
2026-01-09 2026-01-07 PlS Planned sale
Moriarty John B

Chief Legal Officer

Officer
2,374 -3.1%
72.23
US$171,474 		2,374 -3.1% 72.23 US$171,474
2026-01-09 2026-01-07 PlS Planned sale
MacLean Michael F

Chief Financial Officer

Officer
1,974 -3.0%
72.23
US$142,582 		1,974 -3.0% 72.23 US$142,582
2026-01-09 2026-01-07 PlS Planned sale
McCarthy Teresa

Chief Human Resources Officer

Officer
1,965 -1.7%
72.23
US$141,932 		1,965 -1.7% 72.23 US$141,932
2025-10-24 2025-10-22 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
2,209 -5.4%
47.54
US$105,015 		2,209 -5.4% 47.54 US$105,015
2025-10-17 2025-10-15 PlS Planned sale
McCarthy Teresa

Chief Human Resources Officer

Officer
20,000 -17.1%
50.15
US$1,003,058 		20,000 -17.1% 50.15 US$1,003,058
2025-10-07 2025-10-03 PlS Planned sale
Mosbrooker Eric

Chief Commercial Officer

Officer
6,562 -10.7%
45.38
US$297,771 		6,562 -10.7% 45.38 US$297,771
2025-09-23 2025-09-22 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
2,208 -5.4%
40.58
US$89,601 		2,208 -5.4% 40.58 US$89,601
2025-09-17 2025-09-15 PlS Planned sale
McCarthy Teresa

Chief Human Resources Officer

Officer
15,000 -13.4%
41.41
US$621,142 		15,000 -13.4% 41.41 US$621,142
2025-09-17 2025-09-15 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
1,542 -3.8%
45.41
US$70,022 		1,542 -3.8% 45.41 US$70,022
2025-09-12 2025-09-11 PlS Planned sale
Flanagan W. Michael

Chief Scientific Officer

Officer
20,000 -20.0%
38.94
US$778,702 		20,000 -20.0% 38.94 US$778,702
2025-09-11 2025-09-11 PrS Proposed sale
WILLIAM MICHAEL FLANAGAN

Officer

Officer
20,000
46.40
US$928,000 		20,000 46.40 US$928,000
2025-09-09 2025-09-05 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
15,000 -21.6%
50.00
US$750,000 		15,000 -21.6% 50.00 US$750,000
2025-09-09 2025-09-05 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
14,500 -17.3%
50.00
US$725,000 		14,500 -17.3% 50.00 US$725,000
2025-09-05 2025-09-05 PrS Proposed sale
2.8
WILSON TROY EDWARD

Chairman
95,052
50.00
US$4,752,600 		95,052 50.00 US$4,752,600
2025-09-05 2025-09-05 PrS Proposed sale
3.5
SARAH BOYCE

Director; Officer

Executive Director
50,000
48.47
US$2,423,500 		50,000 48.47 US$2,423,500
2025-09-05 2025-09-05 PlS Planned sale
3.5
Boyce Sarah

President and CEO

Executive Director
50,000 -14.1%
49.95
US$2,497,435 		50,000 -14.1% 49.95 US$2,497,435
2025-09-05 2025-09-03 PlS Planned sale
Mosbrooker Eric

Chief Commercial Officer

Officer
6,563 -10.7%
47.07
US$308,936 		6,563 -10.7% 47.07 US$308,936
2025-09-03 2025-09-03 PrS Proposed sale
ERIC MOSBROOKER

Officer

Officer
19,688
47.23
US$929,864 		19,688 47.23 US$929,864
2025-09-02 2025-09-02 PlS Planned sale
Gallagher Kathleen P.

Chief Program Officer

Officer
188 -0.4%
47.42
US$8,915 		188 -0.4% 47.42 US$8,915
2025-08-29 2025-08-28 PlS Planned sale
3.5
Boyce Sarah

President and CEO

Executive Director
25,000 -7.6%
49.39
US$1,234,700 		25,000 -7.6% 49.39 US$1,234,700
2025-08-28 2025-08-28 PrS Proposed sale
3.5
SARAH BOYCE

Director; Officer

Executive Director
25,000
47.82
US$1,195,500 		25,000 47.82 US$1,195,500
2025-08-22 2025-08-22 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
2,208 -5.4%
46.40
US$102,462 		2,208 -5.4% 46.40 US$102,462
2025-08-15 2025-08-15 PrS Proposed sale
TERESA MCCARTHY

Officer

Officer
45,000
46.07
US$2,073,150 		45,000 46.07 US$2,073,150
2025-08-15 2025-08-15 PlS Planned sale
McCarthy Teresa

Chief Human Resources Officer

Officer
10,000 -9.3%
46.56
US$465,632 		10,000 -9.3% 46.56 US$465,632
2025-08-15 2025-08-13 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
1,542 -3.8%
46.66
US$71,950 		1,542 -3.8% 46.66 US$71,950
2025-08-13 2025-08-13 PrS Proposed sale
STEVEN GEORGE HUGHES

Officer

Officer
9,709
46.23
US$448,847 		9,709 46.23 US$448,847
2025-08-15 2025-08-06 PlS Planned sale
MacLean Michael F

Chief Financial Officer

Officer
30,914 -32.0%
42.73
US$1,320,844 		30,914 -32.0% 42.73 US$1,320,844
2025-08-08 2025-08-06 PlS Planned sale
Mosbrooker Eric

Chief Commercial Officer

Officer
6,120 -10.0%
44.06
US$269,663 		6,120 -10.0% 44.06 US$269,663
2025-08-08 2025-08-06 PlS Planned sale
Mosbrooker Eric

Chief Commercial Officer

Officer
124,687 -67.1%
44.06
US$5,494,033 		124,687 -67.1% 44.06 US$5,494,033
2025-08-08 2025-08-06 PlS Planned sale
1.2
LEVIN ARTHUR A
Non-Executive Director
107,500 -84.5%
47.62
US$5,118,881 		107,500 -84.5% 47.62 US$5,118,881
2025-08-08 2025-08-06 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
17,777 -50.0%
45.00
US$799,965 		17,777 -50.0% 45.00 US$799,965
2025-08-08 2025-08-06 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
17,777 -50.0%
45.00
US$799,965 		17,777 -50.0% 45.00 US$799,965
2025-08-08 2025-08-06 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
15,000 -5.0%
45.00
US$675,000 		15,000 -5.0% 45.00 US$675,000
2025-08-08 2025-08-06 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
15,000 -5.0%
45.00
US$675,000 		15,000 -5.0% 45.00 US$675,000
2025-08-08 2025-08-06 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
7,500 -9.7%
45.00
US$337,500 		7,500 -9.7% 45.00 US$337,500
2025-08-08 2025-08-06 PlS Planned sale
2.8
WILSON TROY EDWARD
Non-Executive Director
22,000 -24.1%
45.00
US$990,000 		22,000 -24.1% 45.00 US$990,000
2025-08-08 2025-08-06 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
33,983 -46.6%
42.74
US$1,452,342 		33,983 -46.6% 42.74 US$1,452,342
2025-08-08 2025-08-06 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
17,667 -19.5%
42.74
US$755,040 		17,667 -19.5% 42.74 US$755,040
2025-08-08 2025-08-06 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
6,167 -7.8%
42.74
US$263,561 		6,167 -7.8% 42.74 US$263,561
2025-08-08 2025-08-06 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
12,334 -14.5%
42.74
US$527,122 		12,334 -14.5% 42.74 US$527,122
2025-08-08 2025-08-06 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
11,283 -13.4%
42.74
US$482,205 		11,283 -13.4% 42.74 US$482,205
2025-08-06 2025-08-06 PrS Proposed sale
2.8
WILSON TROY EDWARD

Chairman
95,054
45.00
US$4,277,430 		95,054 45.00 US$4,277,430
2025-08-06 2025-08-06 PrS Proposed sale
ERIC MOSBROOKER

Officer

Officer
130,807
38.26
US$5,004,676 		130,807 38.26 US$5,004,676
2025-08-06 2025-08-06 PrS Proposed sale
STEVEN GEORGE HUGHES

Officer

Officer
81,434
38.26
US$3,115,665 		81,434 38.26 US$3,115,665
2025-08-06 2025-08-06 PrS Proposed sale
1.2
ARTHUR LEVIN

Director

Non-Executive Director
107,500
38.26
US$4,112,950 		107,500 38.26 US$4,112,950
2025-08-06 2025-08-06 PrS Proposed sale
MICHAEL MACLEAN

Officer

Officer
30,914
38.26
US$1,182,770 		30,914 38.26 US$1,182,770
2025-08-05 2025-08-04 PlS Planned sale
Moriarty John B

Chief Legal Officer

Officer
2,245 -4.5%
36.21
US$81,291 		2,245 -4.5% 36.21 US$81,291
2025-06-18 2025-06-17 PlS Planned sale
Gallagher Kathleen P.

Chief Program Officer

Officer
911 -1.8%
30.24
US$27,549 		911 -1.8% 30.24 US$27,549
2025-06-17 2025-06-17 PrS Proposed sale
KATHLEEN GALLAGHER

Officer

Officer
911
29.80
US$27,148 		911 29.80 US$27,148
2025-06-12 2025-06-11 PlS Planned sale
Flanagan W. Michael

Chief Scientific Officer

Officer
20,000 -20.0%
32.88
US$657,694 		20,000 -20.0% 32.88 US$657,694
2025-06-11 2025-06-11 PrS Proposed sale
WILLIAM MICHAEL FLANAGAN

Officer

Officer
20,000
33.62
US$672,400 		20,000 33.62 US$672,400
2025-06-04 2025-06-02 PlS Planned sale
Gallagher Kathleen P.

Chief Program Officer

Officer
5,875 -10.4%
32.48
US$190,833 		5,875 -10.4% 32.48 US$190,833
2025-06-02 2025-06-02 PrS Proposed sale
KATHLEEN GALLAGHER

Officer

Officer
5,875
30.98
US$182,008 		5,875 30.98 US$182,008
2025-05-02 2025-05-01 PlS Planned sale
Gallagher Kathleen P.

Chief Program Officer

Officer
5,875 -10.4%
32.40
US$190,324 		5,875 -10.4% 32.40 US$190,324
2025-05-01 2025-05-01 PrS Proposed sale
KATHLEEN GALLAGHER

Officer

Officer
5,875
32.65
US$191,819 		5,875 32.65 US$191,819
2025-04-03 2025-04-01 PlS Planned sale
Gallagher Kathleen P.

Chief Program Officer

Officer
329 -0.6%
27.83
US$9,155 		329 -0.6% 27.83 US$9,155
2025-04-03 2025-04-01 PlS Planned sale
Gallagher Kathleen P.

Chief Program Officer

Officer
5,546 -9.9%
27.83
US$154,331 		5,546 -9.9% 27.83 US$154,331
2025-03-21 2025-03-20 PlS Planned sale
3.5
Boyce Sarah

President and CEO

Executive Director
31,540 -9.3%
31.06
US$979,563 		31,540 -9.3% 31.06 US$979,563
2025-03-21 2025-03-20 PlS Planned sale
Flanagan W. Michael

Chief Scientific Officer

Officer
11,780 -12.8%
31.06
US$365,868 		11,780 -12.8% 31.06 US$365,868
2025-03-21 2025-03-20 PlS Planned sale
Hughes Steven George

Chief Medical Officer

Officer
9,578 -11.6%
31.06
US$297,491 		9,578 -11.6% 31.06 US$297,491
Explore more

More insider trading research around Avidity Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America